Actively Recruiting

Phase Not Applicable
Age: 6Months - 24Months
All Genders
ID06876259

Intelligent Medical Assessment for Guiding Ear Infection Treatment in Young Children With Upper Respiratory Symptoms

Led by Timothy Shope · Updated on 2026-01-07

300

Participants Needed

2

Research Sites

26 weeks

Total Duration

On this page

Sponsors

T

Timothy Shope

Lead Sponsor

M

Merck Sharp & Dohme LLC

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the use of an artificial intelligence (AI) app to improve the diagnosis and treatment of ear infections in young children aged 6 to 24 months who have cold symptoms. Ear infections can be hard to diagnose accurately in this age group due to small ear canals and limited examination time. The study aims to see how the AI app affects clinical decisions about ear infections and antibiotic use compared to standard clinical exams. The study involves 300 children who will have their ears examined both with the AI app using a smartphone-attached otoscope and by a clinician using a standard otoscope. Each child will receive two ear exams during a single visit. The AI app records and analyzes images to provide a diagnosis and treatment recommendation, which is compared to the clinician's diagnosis. Clinicians will then review the AI app's findings before making a final treatment decision. The study uses a within-subject design where each child's ears are assessed by both methods to compare antimicrobial prescription rates and diagnosis accuracy. Participants will be monitored for 10 days after enrollment to track symptom changes and any side effects from antibiotic use, such as diarrhea or diaper rash. Parents will enter daily symptom scores in electronic diaries. Medical records will be reviewed for three months to identify any recurrences of ear infections. The primary outcome is the rate of antimicrobial prescriptions on the day of diagnosis. Secondary outcomes include diagnostic rates, image quality, symptom severity scores, and infection recurrences. The total study participation involves one visit for exams and follow-up symptom tracking and record review.

CONDITIONS

Brief Title

Artificial Intelligence Diagnostic Decision Support to Reduce Antimicrobial Prescriptions in Young Children With Colds

Who Can Participate

Age: 6Months - 24Months
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 6 and 24 months
  • Presence of upper respiratory infection symptoms
Not Eligible

You will not qualify if you...

  • No upper respiratory infection symptoms
  • Presence of ear drainage (otorrhea)
  • Presence of tympanostomy tubes (ear tubes)
  • Currently taking antimicrobial medications

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Single day visit

Participants undergo two ear exams: one with the AI app by study personnel and one standard clinical exam by the clinician, both blinded to each other's diagnosis. Diagnoses and treatment decisions are recorded for comparison.

1 visit (in-person)

Symptom Monitoring

Duration - 10 to 11 days

Participants' symptoms are monitored daily for 10 days using an electronic diary entered by parents. If symptoms worsen significantly, participants are contacted and offered a visit. Side effects of antimicrobial use are also assessed during this period.

Daily symptom reporting by parents (remote)

Long-term Monitoring

Duration - 3 months

Participants' medical records are reviewed for 3 months after enrollment to monitor for acute otitis media recurrences.

No visits; medical record review only

Trial Site Locations

Total: 2 locations

1

Children's Community Pediatrics Brentwood

Pittsburgh, Pennsylvania, United States, 15227

Actively Recruiting

2

Children's Community Pediatrics Castle Shannon

Pittsburgh, Pennsylvania, United States, 15234

Actively Recruiting

Loading map...

Research Team

T

Timothy R Shope, MD, MPH

N

Nader Shaikh, MD, MPH

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

Evaluation of the Medentum Diagnostik Platform for Pediatric...

Acute Otitis Media (AOM)

Actively Recruiting

1 location

Safety and Efficacy of Whole-Cell Pneumococcal Vaccine (wSp)...

Acute Otitis Media (AOM)

Actively Recruiting

7 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial